Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review

Abstract

Background Recent data suggest that the risk of young-onset colorectal cancer (yCRC), in adults less than 50 years of age, is increasing. To confirm findings and identify contemporary trends worldwide, we conducted a systematic review of studies examining population-level trends in yCRC epidemiology. Methods We searched MEDLINE (1946–2018), EMBASE (1974–2018), CINAHL (1982–2018), and Cochrane Database of Systematic Reviews (2005–2018) for studies that used an epidemiologic design, assessed trends in yCRC incidence or prevalence, and published in English. Extracted information included country, age cut-off for yCRC, and reported trends in incidence or prevalence (e.g. annual percent change [APC]). We pooled similarly reported trend estimates using random effects models. Results Our search yielded 8695 articles and after applying our inclusion criteria, we identified 40 studies from 12 countries across five continents. One study assessed yCRC prevalence trends reporting an APCp of + 2.6 and + 1.8 among 20–39 and 40–49 year olds, respectively. 39 studies assessed trends in yCRC incidence but with substantial variability in reporting. Meta-analysis of the most commonly reported trend estimate yielded a pooled overall APCi of + 1.33 (95% CI, 0.97 to 1.68; p < 0.0001) that is largely driven by findings from North America and Australia. Also contributing to these trends is the increasing risk of rectal cancer as among 14 studies assessing cancer site, nine showed an increased risk of rectal cancer in adults less than 50 years with APCi up to + 4.03 (p < 0.001). Conclusions Our systematic review highlights increasing yCRC risk in North America and Australia driven by rising rectal cancers in younger adults over the past two decades.

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy

“…Colorectal cancer (CRC) is one of the most commonly occurring cancers worldwide with a remarkable increase in incidence among adults younger than 50 years [ 1 , 2 ]. Approximately 35% of CRC diagnoses are located distal to the recto-sigmoid junction and specified as rectal cancer [ 3 ].…”

“…In the past, clinical parameters such as cT and cN stage have been found to be predictive of treatment response. More recently, various molecular biomarkers including gene expression profiles, DNA methylation, and miRNA patterns have been proposed as predictors of response to nRCT; however, determination of these parameters is associated with time-consuming procedures and laboratory efforts [ 1 , 2 , 3 ]. Therefore, the establishment of easily assessable and available pre-treatment prognostic biomarkers is warranted and intensively studied [ 9 ].…”

The Role of HOX Genes as Potential Biomarkers in Colorectal Cancer: A Systematic Review

“…In recent years with the change in people's lifestyle and dietary factors, the incidence of CRC is increasing, especially in the younger population, making this disease a public health burden [54]. Since recurrence and development of distant metastases are the major causes of cancer-related mortality, it is crucial to investigate and discover new molecular markers that contribute to CRC aggressiveness and which may affect survival.…”

Sporadic colorectal cancer in adolescents and young adults: a scoping review of a growing healthcare concern

“…Although the absolute incidence of colon and rectal cancers in young adults ≤ 49 years of age is low overall, a change in epidemiology with a significant rise in incidence has been clearly documented in the literature [3,5,29]. A recently published systematic review by Saad El Din et al, assessing population trends of CRC in AYAs, highlights the increasing risk of CRC in this patient cohort, largely driven by rectal cancers [29]. Current guidelines do not reflect this epidemiological shift, which poses new challenges in screening, diagnosis and management.…”